I am...
I am...
Histio Education
One of the primary goals of the Histiocytosis Association is to provide the Histio Community with information that can help you better understand histiocytic disorders, their diagnosis, treaments and possible long-term effects. Click any of the sections below to engage with a wide range of educational content, or scroll down to see our News Reader for articles and content recently shared on the web.
Educational Video Series
Webinars
Regional Meetings
Histio News Reader
Some of the articles presented on this website are accessed through RSS feeds from third-party sources that are not necessarily part of the Histiocytosis Association. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by the Histiocytosis Association.
If you know of a histio-related article that isn't shown here, please send the article to outreach@histio.org.
- Rosai-Dorfman-Destombes disease of the pancreas: the great ... - The Lancet March 31, 2023
- Jamieson Wellness Inc. Announces Filing of Management Information Circular for Annual and Special Meeting of Shareholders - Investing News Network March 31, 2023
- Neoadjuvant Opdivo (nivolumab) with Chemotherapy Demonstrates ... - Business Wire March 30, 2023
- FDA Converts to Full Approval Indication for KEYTRUDA ... - Merck March 29, 2023
- Golden retriever's cancer treatment gives veterinary student ... - Virginia Tech Daily March 29, 2023
- This rare cancer-like condition most commonly occurs in children under 10 - Times of India March 29, 2023
- Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemotherapy alone - Marketscreener.com March 27, 2023
- KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly ... - Merck March 27, 2023
- An Unusual and Rare Location of Intra-articular Rheumatoid Nodule ... - Cureus March 27, 2023
- Rosai-Dorfman: Rare Manifestations of a Rare Disease - Cureus March 25, 2023
- An Mpox-Related Death in the United States | NEJM - nejm.org March 30, 2023
- Nomogram for predicting child massive necrotizing pneumonia | IDR - Dove Medical Press March 29, 2023
- Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemotherapy alone - Marketscreener.com March 27, 2023
- Hemophagocytic Lymphohistiocytosis Masquerading as ... - Cureus March 23, 2023
- The Challenging Aspect of Macrophage Activation Syndrome in the ... - Cureus March 16, 2023
- Hemophagocytic Lymphohistiocytosis Caused by a Severe Epstein ... - Cureus March 15, 2023
- IMFINZI significantly improved event-free survival in AEGEAN Phase ... - Business Wire March 9, 2023
- Primary Cutaneous Gamma-Delta T-cell Lymphoma: A Case Report ... - Cureus February 25, 2023
- Microscale combinatorial stimulation of human myeloid cells reveals ... - Science February 24, 2023
- Fatal Case of Heartland Virus Disease Acquired in the Mid-Atlantic ... - CDC February 23, 2023
- With a CAGR of 30.8%, Asia-Pacific CAR-T Cell Therapy Treatment Market Share, Size, Worth USD 267.08 Million b - openPR March 31, 2023
- Joe Lofaro – NWTN Today - Weakley County Press March 13, 2023
- Immunologic Effect of Bivalent mRNA Booster in Patients ... - nejm.org March 9, 2023
- “Hairy Kidney” in Erdheim–Chester Disease | NEJM - nejm.org March 9, 2023
- Rosai-Dorfman Disease: Case Series and Literature Review - Cureus February 20, 2023
- FDA Approves First Treatment for Patients With All Forms of ... - On Cancer - Memorial Sloan Kettering January 30, 2023
- Ataxia: symptoms, causes and treatment - Emergency Live International January 27, 2023
- Drafting a New Class of Rare Disease Researchers - CSL Behring January 17, 2023
- Ten Emerging Rare Disease Scientists Score Research Grants ... - PR Newswire January 10, 2023
- Cherry angiomas: what they are and how to remove them - Emergency Live International January 4, 2023
- Diffuse Neurofibroma in a Micronesian Male | Article - Cureus March 22, 2023
- Non-ossifying Fibroma of Mandible in a Four-Year-Old Girl: A Case ... - Cureus March 21, 2023
- The Intersection Between Malaria Treatment and Chemoprophylaxis ... - Cureus March 13, 2023
- Paraneoplastic Aquagenic Pruritus: A Case of Pancreatic Cancer - Cureus February 28, 2023
- Tissue Adhesives for the Management of Corneal Perforations | OPTH - Dove Medical Press January 15, 2023
- Long-term presence of autoantibodies in plasma of cured leprosy ... - Nature.com January 5, 2023
- DNB Dermatology, Venereology and Leprosy: Admissions, Medical Colleges, Fees, Eligibility criteria - Medical Dialogues November 28, 2022
- Man presents with unilateral vision loss, white spot in eye - Healio November 18, 2022
- An unusual presentation of giant juvenile xanthogranuloma in a 9 ... - Archives of Disease in Childhood September 20, 2022
- A Rare Case of Combined Langerhans Cell Histiocytosis and Adult ... - Cureus August 31, 2022
- Rosai-Dorfman-Destombes disease of the pancreas: the great ... - The Lancet March 31, 2023
- Vernal Keratoconjunctivitis Market to Witness Upsurge in Growth ... - Digital Journal March 30, 2023
- Metastatic Breast Cancer Pipeline Assessment, 2023 Updates | In ... - Digital Journal March 30, 2023
- Hereditary Angioedema Market Report 2032: Epidemiology Data ... - Digital Journal March 30, 2023
- Myelofibrosis Pipeline Report: In-depth Analysis into the Clinical ... - Digital Journal March 30, 2023
- Hypovolemic Shock Market to Observe Impressive Growth During ... - Digital Journal March 30, 2023
- Chronic Pulmonary Hypertension Market is Expected to Expand at a ... - Digital Journal March 30, 2023
- EGFR-Non Small Cell Lung Cancer Market to Exhibit Moderate ... - Digital Journal March 30, 2023
- AL Amyloidosis Market Report 2032: Epidemiology Data, Pipeline ... - Digital Journal March 29, 2023
- Multiple Sclerosis Market to Observe Impressive Growth During the ... - Digital Journal March 29, 2023
- Vasopressin Antagonists Market to Reach USD 2.7 Bn by 2031 ... - Digital Journal March 31, 2023
- Last chance to get cheaper NHS prescriptions as price hike hits tomorrow... - The US Sun March 31, 2023
- Family speaks on student's passing – The Troubadour Online - The Troubadour Online March 28, 2023
- Global Rare Endocrine Disease Treatment Market to Reach $12.9 Billion by 2030 - Yahoo Finance March 28, 2023
- The Effect of Vitamin D Supplementation on Incidence of Type 2 ... - Cureus March 28, 2023
- Renal Amyloid-Associated (AA) Amyloidosis in a Sickle Cell Patient ... - Cureus March 24, 2023
- Treating hypopituitarism in the over 65s | CIA - Dove Medical Press March 21, 2023
- mRNA therapy at the convergence of genetics and nanomedicine - Nature.com March 17, 2023
- BRAF, MEK inhibitors 'saving lives' as histiocytic disorder treatment - Healio March 17, 2023
- 'Never give up': SA marathon champ Bothma overcomes obstacles for first title - EWN March 15, 2023
- WATCH | A 4-year-old boy with a rare disease inspires over 70 volunteers to compete in Two Oceans - News24 April 1, 2023
- I have a rare condition that causes my body to produce BEER - Daily Mail March 31, 2023
- Chiesi Global Rare Diseases Announces Approval of FERRIPROX ... - PR Newswire March 31, 2023
- Chiesi Global Rare Diseases Announces Approval of FERRIPROX™ MR Deferiprone Extended-Release Tablets in Canada - Yahoo Finance March 31, 2023
- Michigan House passes bill to create Rare Disease Advisory ... - State of Reform March 31, 2023
- Columbia ballerina fighting for her life after rare diagnosis - WACH.com March 31, 2023
- FDA Approves Evkeeza for Young Children with Ultra-Rare Form of ... - BioPharm International March 31, 2023
- Emmy Award-Winning NBC News Journalist Peter Alexander to ... - PR Newswire March 31, 2023
- Adrenal cancer, the rare but deadly disease that has struck Anna 'Chickadee' Cardwell - Daily Mail March 31, 2023
- Larimar Therapeutics to Participate in the Guggenheim Genomic ... - MyChesCo March 31, 2023